Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

FRA:TR1 - Deutsche Boerse Ag - US74144T1088 - Common Stock - Currency: EUR

77.86  -0.02 (-0.03%)

Fundamental Rating

7

Overall TR1 gets a fundamental rating of 7 out of 10. We evaluated TR1 against 108 industry peers in the Capital Markets industry. While TR1 has a great health rating, its profitability is only average at the moment. TR1 is valued quite cheap, while showing a decent growth score. This is a good combination! Finally TR1 also has an excellent dividend rating. This makes TR1 very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

TR1 had positive earnings in the past year.
TR1 had a positive operating cash flow in the past year.
In the past 5 years TR1 has always been profitable.
TR1 had a positive operating cash flow in each of the past 5 years.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

TR1 has a better Return On Assets (15.17%) than 95.37% of its industry peers.
TR1 has a better Return On Equity (19.76%) than 87.04% of its industry peers.
TR1's Return On Invested Capital of 14.11% is amongst the best of the industry. TR1 outperforms 94.44% of its industry peers.
TR1 had an Average Return On Invested Capital over the past 3 years of 15.27%. This is significantly above the industry average of 7.91%.
Industry RankSector Rank
ROA 15.17%
ROE 19.76%
ROIC 14.11%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

TR1 has a better Profit Margin (28.82%) than 77.78% of its industry peers.
In the last couple of years the Profit Margin of TR1 has declined.
TR1 has a Operating Margin of 33.52%. This is in the better half of the industry: TR1 outperforms 75.00% of its industry peers.
In the last couple of years the Operating Margin of TR1 has declined.
Industry RankSector Rank
OM 33.52%
PM (TTM) 28.82%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The number of shares outstanding for TR1 has been reduced compared to 1 year ago.
Compared to 5 years ago, TR1 has less shares outstanding
The debt/assets ratio for TR1 has been reduced compared to a year ago.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

TR1 has an Altman-Z score of 6.16. This indicates that TR1 is financially healthy and has little risk of bankruptcy at the moment.
TR1 has a better Altman-Z score (6.16) than 93.52% of its industry peers.
TR1 has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.05, TR1 belongs to the top of the industry, outperforming 98.15% of the companies in the same industry.
TR1 has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.01, TR1 belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 6.16
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

TR1 has a Current Ratio of 3.76. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
TR1's Current ratio of 3.76 is amongst the best of the industry. TR1 outperforms 85.19% of its industry peers.
TR1 has a Quick Ratio of 3.76. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of TR1 (3.76) is better than 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 3.76
Quick Ratio 3.76
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

TR1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.76%, which is quite impressive.
TR1 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.42% yearly.
Looking at the last year, TR1 shows a quite strong growth in Revenue. The Revenue has grown by 9.80% in the last year.
The Revenue has been growing slightly by 4.78% on average over the past years.
EPS 1Y (TTM)22.76%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%23.26%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%13.9%

3.2 Future

The Earnings Per Share is expected to grow by 3.59% on average over the next years.
Based on estimates for the next years, TR1 will show a small growth in Revenue. The Revenue will grow by 2.79% on average per year.
EPS Next Y-6.08%
EPS Next 2Y-1.5%
EPS Next 3Y-0.96%
EPS Next 5Y3.59%
Revenue Next Year-0.96%
Revenue Next 2Y0.74%
Revenue Next 3Y1.35%
Revenue Next 5Y2.79%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.47, the valuation of TR1 can be described as very reasonable.
82.41% of the companies in the same industry are more expensive than TR1, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.87, TR1 is valued rather cheaply.
The Price/Forward Earnings ratio is 10.09, which indicates a very decent valuation of TR1.
Based on the Price/Forward Earnings ratio, TR1 is valued cheaper than 83.33% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, TR1 is valued rather cheaply.
Industry RankSector Rank
PE 9.47
Fwd PE 10.09
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TR1 is valued cheaply inside the industry as 85.19% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, TR1 is valued cheaper than 82.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.57
EV/EBITDA 6.46
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

TR1 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.92
EPS Next 2Y-1.5%
EPS Next 3Y-0.96%

7

5. Dividend

5.1 Amount

TR1 has a Yearly Dividend Yield of 5.67%, which is a nice return.
The stock price of TR1 dropped by -30.94% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
TR1's Dividend Yield is rather good when compared to the industry average which is at 6.50. TR1 pays more dividend than 83.33% of the companies in the same industry.
TR1's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 5.67%

5.2 History

On average, the dividend of TR1 grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

55.55% of the earnings are spent on dividend by TR1. This is a bit on the high side, but may be sustainable.
The dividend of TR1 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP55.55%
EPS Next 2Y-1.5%
EPS Next 3Y-0.96%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (4/28/2025, 7:00:00 PM)

77.86

-0.02 (-0.03%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)05-02 2025-05-02/bmo
Inst Owners79.04%
Inst Owner ChangeN/A
Ins Owners1.67%
Ins Owner ChangeN/A
Market Cap17.30B
Analysts50
Price Target81.19 (4.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.67%
Yearly Dividend4.47
Dividend Growth(5Y)10.37%
DP55.55%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.33%
Min EPS beat(2)-5.31%
Max EPS beat(2)7.98%
EPS beat(4)2
Avg EPS beat(4)3.64%
Min EPS beat(4)-5.31%
Max EPS beat(4)14.18%
EPS beat(8)6
Avg EPS beat(8)6.9%
EPS beat(12)8
Avg EPS beat(12)2.57%
EPS beat(16)10
Avg EPS beat(16)1.76%
Revenue beat(2)0
Avg Revenue beat(2)-4.57%
Min Revenue beat(2)-4.82%
Max Revenue beat(2)-4.33%
Revenue beat(4)1
Avg Revenue beat(4)-3.55%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)0.07%
Revenue beat(8)2
Avg Revenue beat(8)-2.14%
Revenue beat(12)3
Avg Revenue beat(12)-3.03%
Revenue beat(16)3
Avg Revenue beat(16)-2.52%
PT rev (1m)-24.03%
PT rev (3m)-26.95%
EPS NQ rev (1m)-4.25%
EPS NQ rev (3m)-8.39%
EPS NY rev (1m)-6.73%
EPS NY rev (3m)-8.37%
Revenue NQ rev (1m)-1.78%
Revenue NQ rev (3m)-3.86%
Revenue NY rev (1m)-4.94%
Revenue NY rev (3m)-6.33%
Valuation
Industry RankSector Rank
PE 9.47
Fwd PE 10.09
P/S 2.77
P/FCF 15.57
P/OCF 11.66
P/B 1.9
P/tB 2.68
EV/EBITDA 6.46
EPS(TTM)8.22
EY10.56%
EPS(NY)7.72
Fwd EY9.91%
FCF(TTM)5
FCFY6.42%
OCF(TTM)6.68
OCFY8.58%
SpS28.1
BVpS40.99
TBVpS29.06
PEG (NY)N/A
PEG (5Y)3.92
Profitability
Industry RankSector Rank
ROA 15.17%
ROE 19.76%
ROCE 18.97%
ROIC 14.11%
ROICexc 17.88%
ROICexgc 28.45%
OM 33.52%
PM (TTM) 28.82%
GM N/A
FCFM 17.79%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexcg growth 3Y-16.2%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.02
Cap/Depr 166.63%
Cap/Sales 5.97%
Interest Coverage 250
Cash Conversion 64.04%
Profit Quality 61.74%
Current Ratio 3.76
Quick Ratio 3.76
Altman-Z 6.16
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)22.76%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%23.26%
EPS Next Y-6.08%
EPS Next 2Y-1.5%
EPS Next 3Y-0.96%
EPS Next 5Y3.59%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%13.9%
Revenue Next Year-0.96%
Revenue Next 2Y0.74%
Revenue Next 3Y1.35%
Revenue Next 5Y2.79%
EBIT growth 1Y16.51%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year3.67%
EBIT Next 3Y4.03%
EBIT Next 5Y4.53%
FCF growth 1Y38.52%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y38.27%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%